Erdafitinib,Vinflunine,Docetaxel,Pembrolizumab
Janssen,pierre fabre,Merck
['cohort 1', '#thor', 'erdafitinib', 'pembro']
#asco23 late breaking abstract #thor cohort 1: erdafitinib vs ct/pembro in #uc fgfralt after 1/2l (ici) loriot pfs 5.6 vs 2.7m hr 0.58 os 12.1 vs 7.8m hr 0.64 orr 45.6% 46% g3-4, most common ppe, stomatitis and hyperphosphatemia
#uc #fgfr #research 
Medical Oncologist MD, Vall d'Hebron @vallhebron @VHIO

Vocal Junta Govern @COMBarcelona

Asesor @SalutUIC
#GBM #PhaseI #oncology